N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide

C44H55F2NO7 — CID 3392457

IUPACN-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide
SMILESCC1=CCCC2(C)C(CCC2(O)CN(CC2CCCO2)C(=O)C23CCC(C)(C(=O)O2)C3(C)C)c2ccc(cc2C(=O)c2ccc(F)c(F)c2)CC(O)CC1
InChIInChI=1S/C44H55F2NO7/c1-27-8-6-17-41(4)34(32-14-11-28(22-30(48)13-10-27)23-33(32)37(49)29-12-15-35(45)36(46)24-29)16-18-43(41,52)26-47(25-31-9-7-21-53-31)38(50)44-20-19-42(5,39(51)54-44)40(44,2)3/h8,11-12,14-15,23-24,30-31,34,48,52H,6-7,9-10,13,16-22,25-26H2,1-5H3
InChIKeyDHAZPYOEWCAPST-UHFFFAOYSA-N
MW747.92 g/mol
LogP7.36
Rot. Bonds7

About N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide

N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide (PubChem CID 3392457) has the molecular formula C44H55F2NO7 and a molecular weight of 747.92 g/mol. Its IUPAC name is N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide.

Molecular Properties

Compound NameN-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide
PubChem CID3392457
Molecular FormulaC44H55F2NO7
Molecular Weight747.92 g/mol
Exact Mass747.39
IUPAC NameN-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide
SMILESCC1=CCCC2(C)C(CCC2(O)CN(CC2CCCO2)C(=O)C23CCC(C)(C(=O)O2)C3(C)C)c2ccc(cc2C(=O)c2ccc(F)c(F)c2)CC(O)CC1
InChIInChI=1S/C44H55F2NO7/c1-27-8-6-17-41(4)34(32-14-11-28(22-30(48)13-10-27)23-33(32)37(49)29-12-15-35(45)36(46)24-29)16-18-43(41,52)26-47(25-31-9-7-21-53-31)38(50)44-20-19-42(5,39(51)54-44)40(44,2)3/h8,11-12,14-15,23-24,30-31,34,48,52H,6-7,9-10,13,16-22,25-26H2,1-5H3
InChIKeyDHAZPYOEWCAPST-UHFFFAOYSA-N
XLogP7.36
TPSA113.37 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms54
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500747.92
LogP ≤ 57.36
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide?
The IUPAC name of N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide (CID 3392457) is N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide.
What is the SMILES notation for N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide?
The canonical SMILES for N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide is CC1=CCCC2(C)C(CCC2(O)CN(CC2CCCO2)C(=O)C23CCC(C)(C(=O)O2)C3(C)C)c2ccc(cc2C(=O)c2ccc(F)c(F)c2)CC(O)CC1.
What is the InChIKey of N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide?
The InChIKey is DHAZPYOEWCAPST-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H55F2NO7/c1-27-8-6-17-41(4)34(32-14-11-28(22-30(48)13-10-27)23-33(32)37(49)29-12-15-35(45)36(46)24-29)16-18-43(41,52)26-47(25-31-9-7-21-53-31)38(50)44-20-19-42(5,39(51)54-44)40(44,2)3/h8,11-12,14-15,23-24,30-31,34,48,52H,6-7,9-10,13,16-22,25-26H2,1-5H3.
What are the key properties of N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide?
N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide has a molecular weight of 747.92 g/mol, XLogP of 7.36, 7 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[17-(3,4-difluorobenzoyl)-5,13-dihydroxy-6,10-dimethyl-5-tricyclo[13.2.2.02,6]nonadeca-1(17),9,15,18-tetraenyl]methyl]-4,7,7-trimethyl-3-oxo-N-(oxolan-2-ylmethyl)-2-oxabicyclo[2.2.1]heptane-1-carboxamide is sourced from PubChem (CID 3392457), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).